A review on new approaches to control multi drug resistance staphylococcus aureus

Dr. Virupakshaiah.DBM

Associate Professor, Department of Microbiology Davangere University, Davangere

Received 02nd January 2021, Accepted 24th July 2021


The researches of new antibacterial compounds represent a hot topic which implies both academics and economical factors. The programs of fundamental research in the field of antibiotics have been almost exclusively left in charge of pharmaceutical companies. For the past decades, a regress in the development of new antibiotics efficient in the fight against drug resistance has been registered, partly because of a decreased interest of most large pharmaceutical companies in the antibiotics research and development. The spread of resistant bacteria mutants is an inevitable phenomenon, a real public threat which has reached alarming and unprecedented levels. Community and hospital acquired infections caused by several resistant pathogens, e.g. methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP), vancomycin-resistant Enterococcus (VRE) and multi-drug resistant in Mycobacterium tuberculosis (MDR) are of particular interest. Multidrug resistance is an important threat in hospitalized patients and also long term hospitalization of the patients will develop resistance. To overcome these problems a target based Insilico drug design is an alternative therapy for treatment of Staphylococcus aureus infections and this review focuses on these aspects.

Please cite this article as:

Dr. Virupakshaiah.DBM (2021). A review on new approaches to control multi drug resistance staphylococcus aureus. International Journal of Recent Research and Applied Studies, 8, 7(4), 51-53.






Leave a Reply

Your email address will not be published. Required fields are marked *